FGFR3 and chondrodysplasia: The application of c-type natriuretic peptide (CNP)9, stabilized forms of CNP10,11, parathyroid hormone (PTH)12, FGFR3-binding peptides13, soluble FGFR314, meclizine15, statin16 and FGFR inhibitors17 could all decrease FGFR signals in cell models and elongated bone length in mouse models of FGFR3 chondrodysplasia.